Utah Medical Products (NASDAQ:UTMD) Lowered to “Buy” Rating by StockNews.com

Utah Medical Products (NASDAQ:UTMD) was downgraded by equities research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Thursday.

Utah Medical Products Stock Up 0.1 %

Utah Medical Products stock traded up $0.06 during midday trading on Thursday, reaching $67.23. The company’s stock had a trading volume of 15,983 shares, compared to its average volume of 22,237. Utah Medical Products has a fifty-two week low of $63.38 and a fifty-two week high of $87.86. The company has a market cap of $233.96 million, a P/E ratio of 15.74 and a beta of 0.08. The business has a 50-day simple moving average of $65.98 and a 200-day simple moving average of $67.31.

Hedge Funds Weigh In On Utah Medical Products

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Utah Medical Products by 7.3% during the first quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock worth $13,023,000 after purchasing an additional 12,402 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Utah Medical Products by 5.4% during the second quarter. Dimensional Fund Advisors LP now owns 170,310 shares of the medical instruments supplier’s stock worth $11,378,000 after purchasing an additional 8,700 shares during the last quarter. Brandes Investment Partners LP grew its holdings in shares of Utah Medical Products by 66.2% during the second quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock worth $7,789,000 after purchasing an additional 46,427 shares during the last quarter. Rice Hall James & Associates LLC grew its holdings in shares of Utah Medical Products by 24.3% during the third quarter. Rice Hall James & Associates LLC now owns 83,338 shares of the medical instruments supplier’s stock worth $5,576,000 after purchasing an additional 16,297 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of Utah Medical Products by 2.9% during the second quarter. Bank of New York Mellon Corp now owns 49,604 shares of the medical instruments supplier’s stock worth $3,314,000 after purchasing an additional 1,391 shares during the last quarter. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.